Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,796,312
  • Shares Outstanding, K 180,837
  • Annual Sales, $ 1,704 M
  • Annual Income, $ -23,850 K
  • 60-Month Beta 1.09
  • Price/Sales 13.46
  • Price/Cash Flow 199.02
  • Price/Book 7.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.10
  • Number of Estimates 8
  • High Estimate -0.01
  • Low Estimate -0.19
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
103.08 +22.29%
on 06/12/20
129.89 -2.95%
on 07/07/20
+18.40 (+17.09%)
since 06/10/20
3-Month
79.04 +59.49%
on 04/13/20
129.89 -2.95%
on 07/07/20
+46.51 (+58.47%)
since 04/09/20
52-Week
62.88 +100.48%
on 10/02/19
129.89 -2.95%
on 07/07/20
+40.95 (+48.11%)
since 07/10/19

Most Recent Stories

More News
AbbVie (ABBV) Gets FDA Nod for Another Botox Label Expansion

AbbVie (ABBV) wins the FDA nod for an expanded use of Botox to treat spasticity in pediatric patients aged two years and above including those with lower limb spasticity caused by cerebral palsy.

BMRN : 126.06 (-0.59%)
BAYRY : 17.9800 (+0.45%)
EBS : 94.23 (-0.26%)
ABBV : 96.83 (-1.13%)
Abeona Restarts Enrollment in Connective Tissue Disorder Study

Abeona (ABEO) restarts patient enrollment in phase III VIITAL study of EB-101 for the treatment of recessive dystrophic epidermolysis bullosa.

BMRN : 126.06 (-0.59%)
BMY : 57.43 (-1.17%)
EBS : 94.23 (-0.26%)
ABEO : 3.01 (-10.15%)
CorMedix (CRMD) Jumps: Stock Rises 7.5%

CorMedix (CRMD) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

BMRN : 126.06 (-0.59%)
CRMD : 6.14 (+0.16%)
Unum Therapeutics (UMRX) Catches Eye: Stock Jumps 8.6%

Unum Therapeutics (UMRX) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

BMRN : 126.06 (-0.59%)
UMRX : 3.32 (+10.30%)
Biomarin Pharmac Set to Possibly Pullback After Yesterday's Rally of 1.33%

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $127.21 to a high of $129.89. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high...

BMRN : 126.06 (-0.59%)
BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO

, /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the promotions of to Executive Vice President, Chief Financial Officer and of to Group Vice President, Chief Accounting...

BMRN : 126.06 (-0.59%)
Biomarin Pharmac Shares Up 26.1% Since SmarTrend's Buy Recommendation (BMRN)

SmarTrend identified an Uptrend for Biomarin Pharmac (NASDAQ:BMRN) on May 12th, 2020 at $98.01. In approximately 2 month, Biomarin Pharmac has returned 26.12% as of today's recent price of $123.61.

BMRN : 126.06 (-0.59%)
BioMarin's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in BioMarin Pharmaceutical.

BMRN : 126.06 (-0.59%)
BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference

, /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that , M.D., President, Worldwide Research & Development and , Acting Chief Financial Officer, will participate in the BofA...

BMRN : 126.06 (-0.59%)
Nasdaq Continues to Excel : 5 Best Stocks in ETF

In a tug of war between bulls and bears, the Dow Jones and S&P 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.

BMRN : 126.06 (-0.59%)
LRCX : 339.98 (+1.26%)
INCY : 104.76 (-2.88%)
SGEN : 174.35 (-3.76%)
QQQ : 263.97 (+0.68%)
ZM : 275.87 (+2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 128.57
1st Resistance Point 127.31
Last Price 126.06
1st Support Level 124.90
2nd Support Level 123.74

See More

52-Week High 129.89
Last Price 126.06
Fibonacci 61.8% 104.29
Fibonacci 50% 96.38
Fibonacci 38.2% 88.48
52-Week Low 62.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar